CervoMed Inc. (CRVO) financial statements and ratios from SEC XBRL: revenue $4.01M (TTM), net margin -673.1%, revenue growth -100.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (TTM) | $4.01M |
| Net Margin | -673.1% |
| Revenue Growth (YoY) | -100.0% |
| EPS Growth (YoY) | -8.6% |
| Price / Book | 1.73 |
| Price / Sales | 119.57 |
| Altman Z-Score | -5.80 (distress) |
| Sector P/E (Healthcare) | 21.7 |
CRVO overview · CRVO earnings · CRVO KPIs · CRVO investor relations · CRVO ownership · CRVO peers · CRVO filings
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.